The buyout firm will provide $25 million in debtor-in-possession financing.
Following Agilents EU mandate, Linden hopes to build out the healthcare divestiture.
The Massachusetts buyout firm merges two companies, Health Resources and Vitamin Research Products, to launch a new platform.
A group of investors exits the disposable medical products company to another PE firm.
Marina Bozilenko, after a stint at Kidd & Co., bolsters firm's healthcare coverage.
Our latest roundtable explores how the market for intellectual property has changed amid the downturn.
Does the enthusiasm for healthcare overlook some of the sector's looming questions?
Mid-market dealmakers are optimistic the consolidation in the large market will trickle down.
Much of the stimulus efforts will plug state Medicaid holes, but dealmakers see opportunity in healthcare IT.
The chemical manufacturer has filed for bankruptcy protection for its US business operations and has secured $125 million in debtor-in-possession financing.